Cancer 98 (8): 1735-44, 2003.[PUBMED Abstract] Himelstein AL, Foster JC, Khatcheressian JL, et al.: Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.
JAMA 317 (1): 48-58, 2017.[PUBMED Abstract] Lipton A, Fizazi K, Stopeck AT, et al.: Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials.
Eur J Cancer 48 (16): 3082-92, 2012.[PUBMED Abstract] Introduction Treatment Options for DCIS Current Clinical Trials Ductal carcinomain situ(DCIS) is a noninvasive condition.